Betamethasone + Clioquinol + Gentamicin + Tolnaftate is primarily used to manage bacterial and fungal skin infections and is classified as a topical antifungal, antibacterial, and corticosteroid medicine.
Other uses include managing conditions such as infected eczema or dermatitis, intertrigo, secondary infections of fungal conditions like athlete's foot, minor infected wounds or burns, and otitis externa.
Local skin reactions (burning, itching)
Skin irritation
Dryness of the skin
Folliculitis
Hypertrichosis
Betamethasone + Clioquinol + Gentamicin + Tolnaftate is a combination of two antifungal agents, one antibiotic, and one corticosteroid.
Betamethasone, the corticosteroid component, acts on steroid receptors within skin cells to reduce the production of inflammatory chemicals. This reduces symptoms such as redness, swelling, and itching associated with skin infections.
Clioquinol is one of the antifungal agents. It disrupts the cell membranes of bacteria and fungi, causing them to die and clearing the infection.
Gentamicin is an antibiotic that binds to bacterial ribosomes and interferes with protein synthesis. As a result, it inhibits bacterial growth and leads to their death.
Tolnaftate is an antifungal agent that stops the growth of fungus by interfering with its production of ergosterol, a crucial component of fungal cell membranes.
Taken together, these four components provide a broad-spectrum action against both bacterial and fungal skin infections while also managing inflammation and symptoms associated with these conditions.
Doctor of Medicine
BMS, FMC, MD Resident
Betamethasone + Clioquinol + Gentamicin + Tolnaftate is available as a topical combination in the form of cream, ointment, and lotion.
This combination is intended for use by adults and children over the age of 2 years.
This combination should not be used by individuals who have a known hypersensitivity to any of the active ingredients.
It is also contraindicated for treating fungal infections of the nails (onychomycosis) and bacterial infections caused by mycobacteria.
This combination may interact with oral anticoagulants (such as warfarin and heparin), leading to an increased risk of bleeding, and other topical corticosteroids (such as hydrocortisone).
Co-administration with NSAIDs (such as ibuprofen and naproxen) may increase the risk of gastrointestinal side effects.
Before starting any new medications, it is crucial to consult a doctor.
An overdose is unlikely as it is intended for external use only. Using the prescribed dosage is recommended to avoid any side effects.
If you miss a dose, apply it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose. Do not apply extra medicine to make up for a missed dose.
Most side effects are temporary and generally harmless and resolve when discontinuing this combination. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
If you experience skin irritation or dryness, reducing the number of applications may help.
This medicine can make the skin more sensitive to sunlight. Applying a sunscreen or wearing protective clothing can help manage this side effect.
This combination does not typically affect your ability to drive or operate machinery. However, care should be taken if irritation or other adverse reactions influence your ability to concentrate.
Betamethasone + Clioquinol + Gentamicin + Tolnaftate is classified as pregnancy category C. It should only be used during pregnancy or while breastfeeding if the potential benefits justify the potential risks to the baby. Always consult your doctor before using this medicine during these periods.
Individuals with extensive burns or wounds should exercise caution when using this medicine as there may be an increased risk of systemic absorption leading to side effects.
Keep the affected area clean and dry before applying Betamethasone + Clioquinol + Gentamicin + Tolnaftate.
Avoid scratching the affected area as this may worsen inflammation and increase the risk of infection.
Wear breathable, loose-fitting clothing to avoid friction and further irritation.
Frequently asked questions
The medicine should start showing effects within several days to a week of usage, with inflammation and itchiness subsiding early in the treatment course. However, the exact time may vary depending on the individual and severity of the infection.
No, you should not stop the combination immediately after seeing improvements in your symptoms. You must complete the entire duration of treatment as recommended by your doctor to ensure complete eradication of the infection.
No, you should not apply this medicine without consulting your doctor first. It is specifically designed to manage bacterial and fungal skin infections and may not be suitable for other types of skin conditions.
Topical applications of this combination are generally not associated with mood changes. If you experience any such symptoms, please consult your doctor.
The duration of the effect can vary depending on the severity and type of infection. Your doctor will guide you on the duration of use.
It is advisable to let the medication absorb into your skin for a while before applying make-up. It is best to consult your doctor.
Some individuals may experience allergic reactions to one or more components of this combination. If you notice any signs of an allergic reaction, like rash or itching, please consult your doctor immediately.
Betamethasone + Clioquinol + Gentamicin + Tolnaftate in other salts
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners